Morgan Stanley announces Amgen (NASDAQ:AMGN) $300 price target

By / / Amgen

Morgan Stanley analyst Terence Flynn reinstates Amgen (NASDAQ:AMGN) with a Equal-Weight and announces $300 price target.

Scroll to Top